Optic nerve sheath meningiomas: Visual improvement after stereotactic radiotherapy

被引:56
|
作者
Liu, JK
Forman, S
Hershewe, GL
Moorthy, CR
Benzil, DL
机构
[1] New York Med Coll, Dept Neurosurg, Valhalla, NY 10595 USA
[2] New York Med Coll, Dept Ophthalmol, Valhalla, NY 10595 USA
[3] New York Med Coll, Dept Radiat Oncol, Valhalla, NY 10595 USA
[4] New York Med Coll, Dept Neurosurg, New York, NY USA
[5] New York Med Coll, Dept Ophthalmol, New York, NY USA
[6] New York Med Coll, Dept Radiat Oncol, New York, NY USA
[7] Univ Nevada, Sch Med, Dept Neuroophthalmol, Reno, NV 89557 USA
关键词
anterior visual pathways; optic nerve sheath meningiomas; orbital tumors; stereotactic radiotherapy;
D O I
10.1097/00006123-200205000-00006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: The management of primary optic nerve sheath meningioma (ONSM) is controversial. Surgery often results in postoperative blindness in the affected eye and thus has been abandoned as a treatment option for most patients. When these tumors are left untreated, however, progressive visual impairment ensues, which also leads to blindness. Recently, radiation therapy has gained wider acceptance in the treatment of these lesions. Experience with stereotactic radiotherapy (SRT) in the treatment of ONSMs is limited because of the rare incidence of this tumor. We present a series of patients with ONSM who were treated with SRT. METHODS: Five patients (three women, two men), ranging in age from 40 to 73 years, presented with progressive visual loss with decreased visual field, visual acuity, and color vision affecting six eyes (one patient had tumor involving both optic nerves). One patient also presented with proptosis and diplopia. Five eyes had functional residual vision (range, 20/20 to 20/40), and one eye was completely blind. All five patients were diagnosed clinically and radiographically to have an ONSM. Three were intraorbital, one was intracanalicular as well as intraorbital, and one was a left ONSM extending through the optic foramen into the intracranial space and involving the right optic nerve. The five functional eyes were treated with SRT by use of 1.8-Gy fractions to a cumulative dose of 45 to 54 Gy. RESULTS: Follow-up ranged from 1 to 7 years, and serial magnetic resonance imaging revealed no changes in the size of the tumor in all five patients. Four patients experienced dramatic improvement in visual acuity, visual field, and color vision within 3 months after SRT. One patient remained stable without evidence of visual deterioration or disease progression. None had radiation-induced optic neuropathy. CONCLUSION: SRT may be a viable option for treatment of primary ONSM in patients with documented progressive visual deterioration, and it may be effective in improving or stabilizing remaining functional vision.
引用
收藏
页码:950 / 955
页数:6
相关论文
共 50 条
  • [1] Optic nerve sheath meningiomas: Visual improvement after stereotactic radiotherapy - Comments
    Kondziolka, D
    Adler, JR
    Loeffler, JS
    Gutin, PH
    Pollock, BE
    [J]. NEUROSURGERY, 2002, 50 (05) : 955 - 957
  • [2] Optic nerve sheath meningiomas: The role of stereotactic radiotherapy
    Smee, R.
    Schneider, M.
    Williams, J.
    [J]. Radiosurgery, Vol 6, 2006, 6 : 140 - 151
  • [3] Fractionated Stereotactic Conformal Radiotherapy for Optic Nerve Sheath Meningiomas
    Solda, F.
    Wharram, B.
    Gunapala, R.
    Brada, M.
    [J]. CLINICAL ONCOLOGY, 2012, 24 (08) : E106 - E112
  • [4] Fractionated Stereotactic Radiotherapy for the Management of Optic Nerve Sheath Meningiomas
    Den, R. B.
    Tjoumakaris, S.
    Werner-Wasik, M.
    Evans, J.
    Curran, W. J.
    Andrews, D. W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S486 - S486
  • [5] The visual impact of fractionated stereotactic conformal radiotherapy on seven eyes with optic nerve sheath meningiomas
    Landert, M
    Baumert, BG
    Bosch, MM
    Lütolf, UM
    Landau, K
    [J]. JOURNAL OF NEURO-OPHTHALMOLOGY, 2005, 25 (02) : 86 - 91
  • [6] HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY OF THE OPTIC NERVE SHEATH MENINGIOMAS: AN EFFECTIVE OPTION
    Fariselli, L.
    Marchetti, M.
    Milanesi, I.
    Bianchi, L.
    Bergantin, A.
    Bianchi, S.
    Giombini, S.
    Franzini, A.
    Broggi, G.
    Solero, C. L.
    [J]. NEURO-ONCOLOGY, 2010, 12 : 9 - 10
  • [7] Visual outcome after fractionated stereotactic radiotherapy for optic nerve sheath meningioma
    Kinaci-Tas, B.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S923 - S924
  • [8] Visual outcome after fractionated stereotactic radiotherapy for optic nerve sheath meningioma
    Kinaci-Tas, Buket
    Praag, Y.
    Alderliesten, Tanja
    Verbraak, Frank
    Saeed, Peerooz
    Rasch, C.
    Stalpers, L.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [9] Fractionated radiotherapy for optic nerve sheath meningiomas
    Bloch, Orin
    Sun, Matthew
    Kaur, Gurvinder
    Barani, Igor J.
    Parsa, Andrew T.
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (09) : 1210 - 1215
  • [10] Visual Outcomes and Local Control After Fractionated Stereotactic Radiotherapy for Optic Nerve Sheath Meningioma
    Hamilton, Sarah Nicole
    Nichol, Alan
    Truong, Pauline
    McKenzie, Michael
    Hsu, Fred
    Cheung, Arthur
    Dolman, Peter
    Gete, Ermias
    Ma, Roy
    [J]. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2018, 34 (03): : 217 - 221